Definitive Contract 75D30118C02820
Award Date
9/17/18
Potential Completion Date
9/16/19
Potential Value
$3.2M
Federal Agency
CDC Pittsburgh
Awardee
Cerilliant Corporation
Ultimate Awardee
Not listed
PSC Category
6810 - Chemicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Round Rock, TX 78665, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Cerilliant Corporation was awarded a $4 million firm fixed price delivery order against an unspecified government-wide acquisition contract (GWAC) by the Centers for Disease Control and Prevention (CDC) to provide traceable opioid kits. The delivery order, which has a period of performance through September 2020, calls for Cerilliant to supply CRM kits to support the CDC's efforts to curb the opioid epidemic. No set-aside provisions were applied to this sole source award to Cerilliant, located...
This federal contract award to Cerilliant Corporation, a foreign-owned manufacturer based in Round Rock, Texas, is for the supply of drug standards used for screening and confirmation testing of urine, blood, and tissue samples from service members suspected of drug use. The $10,010.88 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call with the Defense Health Agency (DHA), a defense agency. Cerilliant, which has over 30 years of experience as a government contractor, will...
This is a federal contract award to Cerilliant Corporation, a foreign-owned, for-profit manufacturer of chemical and biological reference materials based in Round Rock, Texas. The contract, awarded by the Defense Health Agency (DHA), is for the provision of medical supplies. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type and a ceiling value of $32,348.38. The contract is set to expire on September 30, 2023. Cerilliant Corporation has a history of...
The U.S. Defense Health Agency awarded a Blanket Purchase Agreement (BPA) Call contract worth $24,406.52 to Cerilliant Corporation, a foreign-owned, for-profit manufacturer based in Round Rock, Texas. The contract is for the provision of drug standards to be used for drug screening and confirmation testing of U.S. service member specimens. This contract is part of a larger $250,000 BPA with the Defense Health Agency that runs through September 2028, as well as a $746,914.62 BPA covering the...
Cerilliant Corporation, a foreign-owned manufacturer, was awarded a firm fixed price BPA call contract by the Defense Health Agency to provide products for screening and analysis of suspected drug use. The $12,175.61 contract has a completion date of September 30, 2024 and does not utilize any set-aside designations. Cerilliant is a long-standing federal contractor, delivering certified reference standards, reagents, and laboratory materials to support research, testing, and healthcare...
This federal contract award is a Blanket Purchase Agreement (BPA) call issued by the Defense Health Agency (DHA) to Cerilliant Corporation, a global leader in certified reference materials and laboratory supplies. The contract, valued at $8,279.36, is for the provision of drug reference standards to support the DHA's drug screening and testing programs for service members. Cerilliant Corporation is a foreign-owned, for-profit manufacturer based in Texas, with over 30 years of experience as a...
This firm fixed-price contract award to Cerilliant Corporation, a foreign-owned for-profit manufacturer, is for the provision of drug standards that will be used for screening and testing of service members' specimens. The contract, valued at $12,538.24, was awarded by the Defense Health Agency on March 26, 2024, with a completion date of September 30, 2024. This appears to be a call under a larger Blanket Purchase Agreement (BPA) vehicle, as the contract type is listed as "BPA...
This federal contract award to Cerilliant Corporation is a Blanket Purchase Agreement (BPA) call with the Defense Health Agency (DHA), valued at $15,522.70. The contract is for the provision of drug reference standards and calibration materials to support drug testing and screening of service member specimens, including post-mortem urine, blood, and tissue samples. The contract has a completion date of August 15, 2024 and is a firm fixed price arrangement. Cerilliant Corporation is a global...
Cerilliant Corporation was awarded a firm fixed price call against the Blanket Purchase Agreement with the Defense Health Agency with a potential value of $19,158.95. The contract is for the provision of reference standards, reagents, calibrators and other laboratory materials to support testing and healthcare programs at Fort Meade, Maryland. No set aside designation was applied. Cerilliant is a global leader in supplying chemical and biological reference standards to federal agencies. They...
This federal contract award is a BPA (Blanket Purchase Agreement) call for drug reference standards and related supplies from Cerilliant Corporation, a global leader in certified reference materials. The contract has a total ceiling value of $9,906.25 and is awarded to Cerilliant by the Defense Health Agency (DHA), a defense agency within the Department of Defense. The contract delivers drug reference standards, calibrators, reagents, and laboratory materials to support research, testing,...